Sudhir V. Valia at Sun Pharma
Sun Pharmaceutical Industries Limited

Leadership at
Sun Pharma

Whole-Time Director driving finance, operations, and strategic growth at one of the world's largest pharmaceutical companies.

Whole-Time Director

As Whole-Time Director at Sun Pharmaceutical Industries Limited, Sudhir V. Valia plays a pivotal role in shaping the financial and operational direction of one of the world's largest specialty generic pharmaceutical companies. His responsibilities span across multiple domains, reflecting his versatility and depth as a corporate leader.

Sun Pharma, headquartered in Mumbai, India, is the fourth-largest specialty generic pharmaceutical company globally, with operations spanning over 40 countries. Sudhir V. Valia's leadership contributes directly to the company's continued growth, operational efficiency, and market leadership.

Sudhir V. Valia — Corporate Event

Domains of
Leadership

Finance

Overseeing corporate financial strategy, capital allocation, treasury management, and investor relations for a multi-billion-dollar global operation.

Operations

Driving operational excellence across manufacturing, supply chain, and distribution networks that serve markets worldwide.

Quality Control

Ensuring the highest standards of product quality, regulatory compliance, and safety across all manufacturing and R&D facilities.

Projects

Leading strategic projects including capacity expansion, new market entry, and organizational transformation initiatives.

Driving Value at Scale

Under Sudhir V. Valia's stewardship, Sun Pharma has strengthened its position as a global leader in specialty generics. His approach combines rigorous financial discipline with a forward-looking vision for sustainable growth.

Key contributions include:

  • Strengthening the company's financial architecture to support global expansion
  • Implementing robust governance frameworks aligned with international best practices
  • Overseeing critical capital allocation decisions that balance growth with profitability
  • Driving operational improvements across manufacturing and supply chain
  • Ensuring regulatory compliance across 40+ countries of operation
40+
Countries of Operation
4th
Largest Specialty Generic Pharma Company
Global
Manufacturing & R&D Footprint

"At Sun Pharma, excellence is not a goal — it is a standard. Every decision, every initiative, every investment is measured against the enduring commitment to quality, integrity, and patient-centricity."

— Sudhir V. Valia